アンチトロンビンIIIテストの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1843)
◆英語タイトル:Global Anti-thrombin III Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1843
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、アンチトロンビンIIIテストの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(アンチトロンビン欠乏症診断、活性アッセイ、免疫学アッセイ)、用途別市場規模(病院、研究機関、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・アンチトロンビンIIIテストの市場動向
・企業の競争状況、市場シェア
・アンチトロンビンIIIテストの種類別市場規模(アンチトロンビン欠乏症診断、活性アッセイ、免疫学アッセイ)
・アンチトロンビンIIIテストの用途別市場規模(病院、研究機関、診療所、その他)
・アンチトロンビンIIIテストの北米市場規模2016-2027(アメリカ、カナダ)
・アンチトロンビンIIIテストの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・アンチトロンビンIIIテストのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・アンチトロンビンIIIテストの中南米市場規模2016-2027(メキシコ、ブラジル)
・アンチトロンビンIIIテストの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott Laboratories、Danaher Corp.、F. Hoffmann-La Roche Ltd.、Siemens Healthcare GmbH、Thermo Fisher Scientific Inc.)
・結論
【レポートの概要】

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin.
Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
Antithrombin is a serpin (serine protease inhibitor) similar in structure to other plasma protease inhibitors like alpha 1-antichymotrypsin, alpha 2-antiplasmin and Heparin cofactor II.

Market Analysis and Insights: Global Anti-thrombin III Testing Market
The global Anti-thrombin III Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-thrombin III Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-thrombin III Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-thrombin III Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-thrombin III Testing market.

Global Anti-thrombin III Testing Scope and Market Size
Anti-thrombin III Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-thrombin III Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays

Segment by Application
Hospital
Research institute
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis of antithrombin deficiency
1.2.3 Activity assays
1.2.4 Immunological assays
1.3 Market by Application
1.3.1 Global Anti-thrombin III Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-thrombin III Testing Market Perspective (2016-2027)
2.2 Anti-thrombin III Testing Growth Trends by Regions
2.2.1 Anti-thrombin III Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-thrombin III Testing Historic Market Share by Regions (2016-2021)
2.2.3 Anti-thrombin III Testing Forecasted Market Size by Regions (2022-2027)
2.3 Anti-thrombin III Testing Industry Dynamic
2.3.1 Anti-thrombin III Testing Market Trends
2.3.2 Anti-thrombin III Testing Market Drivers
2.3.3 Anti-thrombin III Testing Market Challenges
2.3.4 Anti-thrombin III Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-thrombin III Testing Players by Revenue
3.1.1 Global Top Anti-thrombin III Testing Players by Revenue (2016-2021)
3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Players (2016-2021)
3.2 Global Anti-thrombin III Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-thrombin III Testing Revenue
3.4 Global Anti-thrombin III Testing Market Concentration Ratio
3.4.1 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombin III Testing Revenue in 2020
3.5 Anti-thrombin III Testing Key Players Head office and Area Served
3.6 Key Players Anti-thrombin III Testing Product Solution and Service
3.7 Date of Enter into Anti-thrombin III Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-thrombin III Testing Breakdown Data by Type
4.1 Global Anti-thrombin III Testing Historic Market Size by Type (2016-2021)
4.2 Global Anti-thrombin III Testing Forecasted Market Size by Type (2022-2027)

5 Anti-thrombin III Testing Breakdown Data by Application
5.1 Global Anti-thrombin III Testing Historic Market Size by Application (2016-2021)
5.2 Global Anti-thrombin III Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-thrombin III Testing Market Size (2016-2027)
6.2 North America Anti-thrombin III Testing Market Size by Type
6.2.1 North America Anti-thrombin III Testing Market Size by Type (2016-2021)
6.2.2 North America Anti-thrombin III Testing Market Size by Type (2022-2027)
6.2.3 North America Anti-thrombin III Testing Market Size by Type (2016-2027)
6.3 North America Anti-thrombin III Testing Market Size by Application
6.3.1 North America Anti-thrombin III Testing Market Size by Application (2016-2021)
6.3.2 North America Anti-thrombin III Testing Market Size by Application (2022-2027)
6.3.3 North America Anti-thrombin III Testing Market Size by Application (2016-2027)
6.4 North America Anti-thrombin III Testing Market Size by Country
6.4.1 North America Anti-thrombin III Testing Market Size by Country (2016-2021)
6.4.2 North America Anti-thrombin III Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-thrombin III Testing Market Size (2016-2027)
7.2 Europe Anti-thrombin III Testing Market Size by Type
7.2.1 Europe Anti-thrombin III Testing Market Size by Type (2016-2021)
7.2.2 Europe Anti-thrombin III Testing Market Size by Type (2022-2027)
7.2.3 Europe Anti-thrombin III Testing Market Size by Type (2016-2027)
7.3 Europe Anti-thrombin III Testing Market Size by Application
7.3.1 Europe Anti-thrombin III Testing Market Size by Application (2016-2021)
7.3.2 Europe Anti-thrombin III Testing Market Size by Application (2022-2027)
7.3.3 Europe Anti-thrombin III Testing Market Size by Application (2016-2027)
7.4 Europe Anti-thrombin III Testing Market Size by Country
7.4.1 Europe Anti-thrombin III Testing Market Size by Country (2016-2021)
7.4.2 Europe Anti-thrombin III Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombin III Testing Market Size (2016-2027)
8.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type
8.2.1 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application
8.3.1 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-thrombin III Testing Market Size by Region
8.4.1 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-thrombin III Testing Market Size (2016-2027)
9.2 Latin America Anti-thrombin III Testing Market Size by Type
9.2.1 Latin America Anti-thrombin III Testing Market Size by Type (2016-2021)
9.2.2 Latin America Anti-thrombin III Testing Market Size by Type (2022-2027)
9.2.3 Latin America Anti-thrombin III Testing Market Size by Type (2016-2027)
9.3 Latin America Anti-thrombin III Testing Market Size by Application
9.3.1 Latin America Anti-thrombin III Testing Market Size by Application (2016-2021)
9.3.2 Latin America Anti-thrombin III Testing Market Size by Application (2022-2027)
9.3.3 Latin America Anti-thrombin III Testing Market Size by Application (2016-2027)
9.4 Latin America Anti-thrombin III Testing Market Size by Country
9.4.1 Latin America Anti-thrombin III Testing Market Size by Country (2016-2021)
9.4.2 Latin America Anti-thrombin III Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombin III Testing Market Size (2016-2027)
10.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type
10.2.1 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application
10.3.1 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-thrombin III Testing Market Size by Country
10.4.1 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-thrombin III Testing Introduction
11.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Danaher Corp.
11.2.1 Danaher Corp. Company Details
11.2.2 Danaher Corp. Business Overview
11.2.3 Danaher Corp. Anti-thrombin III Testing Introduction
11.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.2.5 Danaher Corp. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Siemens Healthcare GmbH
11.4.1 Siemens Healthcare GmbH Company Details
11.4.2 Siemens Healthcare GmbH Business Overview
11.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Introduction
11.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2016-2021)
11.4.5 Siemens Healthcare GmbH Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Details
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.5.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ アンチトロンビンIIIテストの世界市場規模・現状・予測2021年-2027年(Global Anti-thrombin III Testing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。